Position in GSK
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$1,198,373
-$71,383 QoQ
Shares Held
22,861
-0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
#327
of 1,032 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOWER TRUST & INVESTMENT Co holds $5,569,315 across 10 Drug Manufacturers - General names. GSK ranks #2 (21.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,757 | $1,208,135 | |
| 2 | GSK |
GSK plc
This page
|
22,861 | $1,198,373 | |
| 3 | LLY |
ELI LILLY & Co
|
992 | $1,189,834 | |
| 4 | BIIB |
Biogen Inc.
|
2,818 | $608,857 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
10,147 | $584,670 | |
| 6 | PFE |
Pfizer Inc
|
18,965 | $456,677 | |
| 7 | ABBV |
AbbVie Inc.
|
1,020 | $256,672 | |
| 8 | MRK |
Merck & Co., Inc.
|
468 | $60,138 |
All Filings in GSK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,198,373 | 22,861 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $1,269,756 | 23,007 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $1,126,154 | 22,964 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,001,096 | 23,195 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $879,436 | 22,902 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $863,165 | 22,281 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||